R&D Director
/
    Education：
    • Postdoctoral Research, University of Utah, USA
    • Ph.D. in Pharmaceutics, University of Utah, USA

    Areas of Expertise：
    • Drug Delivery Development
    • Strategic Planning for Innovative Drug R&D
    • Prescription Drug Marketing & Medication-Use Analysis

    Professional Summary :
        Dr. Tsung-Min Hsu (Ph.D. in Pharmaceutics, University of Utah) is a drug delivery expert with 30+ years of experience and 20+ invention patents. He specializes in transforming innovative R&D into successful commercial pharmaceutical products.
    Professional Milestones:
    • Berlex (1990–1992): Developed a bioengineered oral gel for mucosal recovery in cancer patients.
    • Cygnus (1992–1994): Led the development and commercialization of the Ortho-Evra® seven-day contraceptive patch.
    • Dermatreads (1999–2008): As VP of R&D, pioneered peptide transdermal technology and licensed Paliperidone patch formulations to Japan’s Teikoku Pharma.
    • D3forMe (2008–2013): As VP of R&D, spearheaded the development of Vitamin D3 transdermal patches.
    Summary: Dr. Hsu’s career exemplifies a mastery of controlled-release systems and a proven track record in global technology transfer and commercialization.